CoChat

Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction

Open access
Riveros-Mckay, Fernando, Weale, Michael E., Moore, Rachel, Selzam, Saskia, Krapohl, Eva, Sivley, R. Michael, Tarran, William A., Sørensen, Peter, Lachapelle, Alexander S., Griffiths, Jonathan A., Saffari, Ayden, Deanfield, John, Spencer, Chris C.A., Hippisley-Cox, Julia, Hunter, David J., O’Sullivan, Jack W., Ashley, Euan A., Plagnol, Vincent, Donnelly, Peter · 2021 · Circulation: Genomic and Precision Medicine
Cited by 165

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Background: There is considerable interest in whether genetic data can be used to improve standard cardiovascular disease risk calculators, as the latter are routinely used in clinical practice to manage preventative treatment. Methods: Using the UK Biobank resource, we developed our own polygenic risk score for coronary artery disease (CAD). We used an additional 60 000 UK Biobank individuals to develop an integrated risk tool (IRT) that combined our polygenic risk score with established risk tools (either the American Heart Association/American College of Cardiology pooled cohort equations [PCE] or UK QRISK3), and we tested our IRT in an additional, independent set of 186 451 UK Biobank individuals. Results: The novel CAD polygenic risk score shows superior predictive power for CAD events, compared with other published polygenic risk scores, and is largely uncorrelated with PCE and QRISK3. When combined with PCE into an IRT, it has superior predictive accuracy. Overall, 10.4% of incident CAD cases were misclassified as low risk by PCE and correctly classified as high risk by the IRT, compared with 4.4% misclassified by the IRT and correctly classified by PCE. The overall net reclassification improvement for the IRT was 5.9% (95% CI, 4.7–7.0). When individuals were stratified into age-by-sex subgroups, the improvement was larger for all subgroups (range, 8.3%–15.4%), with the best performance in 40- to 54-year-old men (15.4% [95% CI, 11.6–19.3]). Comparable results were found using a different risk tool (QRISK3) and also a broader definition of cardiovascular disease. Use of the IRT is estimated to avoid up to 12 000 deaths in the United States over a 5-year period. Conclusions: An IRT that includes polygenic risk outperforms current risk stratification tools and offers greater opportunity for early interventions. Given the plummeting costs of genetic tests, future iterations of CAD risk tools would be enhanced with the addition of a person’s polygenic risk.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circgen.120.003304

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 165

Metadata

Authors
Riveros-Mckay, F., Weale, M. E., Moore, R., Selzam, S., Krapohl, E., Sivley, R. M., Tarran, W. A., Sørensen, P., Lachapelle, A. S., Griffiths, J. A., Saffari, A., Deanfield, J., Spencer, C. C. A., Hippisley-Cox, J., Hunter, D. J., O’Sullivan, J. W., Ashley, E. A., Plagnol, V., & Donnelly, P.
Venue
Circulation: Genomic and Precision Medicine
Published
2021-04
Volume
14
Issue
2
Pages
e003304-e003304
ISSN
2574-8300 (ISSN-L)
OpenAlex
W3134600603
Cited by
165
References
25
FWCI
14.73
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction. https://app.cochat.ai/papers/10.1161/circgen.120.003304
The paper
Riveros-Mckay, F., Weale, M. E., Moore, R., Selzam, S., Krapohl, E., Sivley, R. M., Tarran, W. A., Sørensen, P., Lachapelle, A. S., Griffiths, J. A., Saffari, A., Deanfield, J., Spencer, C. C. A., Hippisley-Cox, J., Hunter, D. J., O’Sullivan, J. W., Ashley, E. A., Plagnol, V., & Donnelly, P. (2021). Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.120.003304

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.